Xiaoxi Zhou
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Hematology top 10%
- Multiple Myeloma Research and Treatments
Papers in
- Oncology 28
- CAR-T cell therapy research 23
- Cancer Cells and Metastasis 4
- Immunology 10
- Immune Cell Function and Interaction 4
- Biosimilars and Bioanalytical Methods 3
- Co-authors
- Jianfeng Zhou (24 shared papers)Qiangying Yi (10 shared papers)Yao Wu (10 shared papers)Liting Chen (14 shared papers)Ke Kang (6 shared papers)Xia Mao (10 shared papers)Min Xiao (12 shared papers)Jue Wang (7 shared papers)
- Journals
- Blood (5 papers)Frontiers in Immunology (4 papers)Journal of Materials Chemistry B (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Xiaoxi Zhou
52 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 88
- Oncology 559
- Hematology 126
- Immunology 188
- Biomedical Engineering 222
- Biomaterials 66
Countries citing papers authored by Xiaoxi Zhou
This map shows the geographic impact of Xiaoxi Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxi Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxi Zhou more than expected).
Fields of papers citing papers by Xiaoxi Zhou
This network shows the impact of papers produced by Xiaoxi Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxi Zhou. The network helps show where Xiaoxi Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoxi Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 145 | |
| 2 | 2010 | 130 | |
| 3 | 2019 | 60 | |
| 4 | 2019 | 54 | |
| 5 | 2019 | 50 | |
| 6 | 2024 | 50 | |
| 7 | 2018 | 39 | |
| 8 | 2020 | 39 | |
| 9 | 2018 | 34 | |
| 10 | 2021 | 33 | |
| 11 | 2020 | 32 | |
| 12 | 2023 | 32 | |
| 13 | 2020 | 31 | |
| 14 | 2020 | 27 | |
| 15 | 2019 | 26 | |
| 16 | 2019 | 23 | |
| 17 | 2021 | 22 | |
| 18 | 2022 | 22 | |
| 19 | 2019 | 21 | |
| 20 | 2018 | 20 |
About Xiaoxi Zhou
Xiaoxi Zhou is a scholar working on Oncology, Immunology, Biomedical Engineering, Molecular Biology and Pathology and Forensic Medicine, having authored 53 papers that have together received 1.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (23 papers), Lymphoma Diagnosis and Treatment (7 papers), Virus-based gene therapy research (6 papers), Cancer Cells and Metastasis (4 papers), Immune Cell Function and Interaction (4 papers), Biosimilars and Bioanalytical Methods (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). The work is most often cited by research in Oncology (559 citations), Hematology (126 citations), Immunology (188 citations), Biomedical Engineering (222 citations) and Biomaterials (66 citations). Xiaoxi Zhou has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Jianfeng Zhou, Qiangying Yi, Yao Wu, Liting Chen, Ke Kang, Xia Mao, Min Xiao, Jue Wang, Chunrui Li and Fang Lan. Their work appears in journals such as Blood, Frontiers in Immunology, Journal of Materials Chemistry B, Journal for ImmunoTherapy of Cancer and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.